It is therefore not surprising that a high CRC risk is associated with low HDAC2 expression and high B-cell infiltration (Figure 3), while in other conditions, HDAC2 deep deletion may be linked to lower levels of B-cell alteration (Figure 2A). Here, HDAC2 is linked to colorectal carcinoma.